ABOUT
Our mission is to redefine cancer treatment with therapeutics administered exclusively at the tumor site to transform clinical outcomes and minimize side effects.
PanTher’s innovative approach is truly differentiated from current technologies, by enabling drug treatment at the tumor site in high concentrations over an extended period of time. In short, we exclusively and continuously administer drug to where it is needed.
Our platform is applicable across many different types of therapeutics and our name reflects this philosophy.
Leadership & Board of Directors
PanTher’s skilled management team offers decades of experience in oncology, drug development, biomedical implantable therapeutics, and building successful companies. Our leadership experience and diverse set of expertise are the foundation of our success.
Laura Indolfi
Chief Executive Officer and Co‑Founder
John Edwards
Executive Chair of the Board of Directors
Dan Wildman
Board Member
President, Wildman Ventures
Darshana Zaveri
Board Member
Founder and Managing Partner,
Catalyst Health Ventures
Manish Bhandari
Board Member
Founder and Managing Partner,
Angel Physicians Fund
Maria Palasis
Board Member
Chief Executive Officer, Lyra Therapeutics
